Figure 2.
Outcome of ML-DS 2006 patients compared with the historical control arm (AML-BFM 98). (A) EFS, (B) OS, and (C) CIR/NR for ML-DS 2006 patients in comparison with ML-DS children from the previous AML-BFM 98 trial9 (historical control arm). (A-C) Five-year probabilities are given.